Effects of Pitavastatin on Lipid-rich Carotid Plaques Studied Using High-resolution Magnetic Resonance Imaging.

Department of Cardiology, Zhongshan People's Hospital, Zhongshan, Guangdong, China. Department of Medical Imaging, Zhongshan People's Hospital, Zhongshan, Guangdong, China. Department of Neurology, Zhongshan People's Hospital, Zhongshan, Guangdong, China. Deanery, Zhongshan People's Hospital, Zhongshan, Guangdong, China. Electronic address: Yuanyong082316@163.com.

Clinical therapeutics. 2017;(3):620-629
Full text from:

Abstract

PURPOSE This study evaluates the effectiveness of pitavastatin in patients with atherosclerosis. METHODS Sixty patients with atherosclerosis with lipid-rich carotid plaques were included and allocated into low-dose (2 mg/d) and high-dose (4 mg/d) pitavastatin groups with 48 weeks of treatment. Total cholesterol, LDL-C, HDL-C, triglycerides, apolipoprotein A1, apolipoprotein B, lipoprotein (a), and the inflammation-related factors interleukin 6, high-sensitivity C-reactive protein, and homocysteine were determined. High-resolution (3.0-T) magnetic resonance imaging was used to evaluate the lipid core area, plaque thickness, total vessel area, lumen area, wall area, and normalized wall index. FINDINGS After the treatment period, the blood serum values were improved in both groups, but the improvement was significantly better for total cholesterol (P < 0.009), HDL-C, LDL-C, triglycerides, apolipoprotein A1, apolipoprotein B, lipoprotein (a), and homocysteine (all P < 0.001) in the high-dose group. The high-resolution magnetic resonance images revealed great improvements in both groups, although significantly better for the lipid core area (P < 0.001), plaque thickness (P < 0.001), wall area (P < 0.05), normalized wall index (P < 0.001), and lumen area (P < 0.05) in the HD group. Further analyses revealed a close correlation between lipid-rich plaques and changes in blood lipid components. IMPLICATIONS Pitavastatin had significant lipid-lowering and anti-inflammatory effects in patients with atherosclerosis. It also reduced the lipid components and plaques of lipid rich carotid plaques. The effect was obviously stronger in the high-dose than in the low-dose group.

Methodological quality

Publication Type : Randomized Controlled Trial

Metadata